The Effect of a High-Fat Meal on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers

Clinical Pharmacology in Drug Development - United States
doi 10.1002/cpdd.641

Related search